Jubilant HollisterStier
Mark Sassler is a seasoned professional in the pharmaceutical industry with extensive experience in business development and management. Currently serving as the Business Director for the Ophthalmic Business at Jubilant HollisterStier Contract Manufacturing & Services since December 2018, Mark oversees the manufacturing of various ophthalmic dosage forms. Prior to this role, Mark was a Partner and Executive Global Director of Business Development at Clinpak Technologies from May 2008 to December 2018, focusing on generic and biotechnology pharmaceuticals. Mark also held the position of Director of Business Development at Bilcare Limited, where Mark evaluated the viability of entering the CMO arena, and was the Founder, Board Member, and President of Mid-Atlantic Isotopes, a manufacturer of radiopharmaceuticals. Mark holds a Bachelor of Science degree from Bowling Green State University.
This person is not in any teams
This person is not in any offices
Jubilant HollisterStier
Jubilant HollisterStier is an integrated contract manufacturer of sterile injectables, ophthalmics, otics and sterile and non-sterile topicals and liquids. Our facilities in North America provide specialized manufacturing services for the pharmaceutical and biopharmaceutical industries. We provide a full range of support and services to streamline the manufacturing process such as on-site assistance from process qualifications through product release.